MA38084A1 - 2'-chloro nucleoside analogues for treating hepatitis c virus infection - Google Patents

2'-chloro nucleoside analogues for treating hepatitis c virus infection

Info

Publication number
MA38084A1
MA38084A1 MA38084A MA38084A MA38084A1 MA 38084 A1 MA38084 A1 MA 38084A1 MA 38084 A MA38084 A MA 38084A MA 38084 A MA38084 A MA 38084A MA 38084 A1 MA38084 A1 MA 38084A1
Authority
MA
Morocco
Prior art keywords
virus infection
nucleoside analogues
treating hepatitis
chloro
compositions
Prior art date
Application number
MA38084A
Other languages
French (fr)
Inventor
Benjamin Alexander Mayes
Alistair James Stewart
Adel M Moussa
Gilles Gosselin
Christophe Claude Parsy
Francois-Rene Alexandre
Houcine Rahali
Jean-François Griffon
Dominique Surleraux
Cyril B Dousson
Claire Pierra
David Dukhan
Original Assignee
Centre Nat Rech Scient
Univ Montpellier
Idenix Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Montpellier, Idenix Pharmaceuticals Llc filed Critical Centre Nat Rech Scient
Priority claimed from PCT/US2013/063731 external-priority patent/WO2014058801A1/en
Publication of MA38084A1 publication Critical patent/MA38084A1/en

Links

Abstract

La présente invention concerne des composés, des compositions et des méthodes pour le traitement d'infections par des flaviviridés, y compris des infections par le virus de l'hépatite c. Selon certains modes de réalisation, l'invention concerne des composés ou des compositions de dérivés de nucléosides qui peuvent être administrés soit seuls, soit en combinaison avec d'autres agents antiviraux. Dans certains modes de réalisation, les composés consistent en des nucléosides 2'-chloro répondant à la formule 2001 : (2001) ou en un sel, un solvate, une forme stéréo-isomère, une forme tautomère ou une forme polymorphe pharmaceutiquement acceptable associé, et dans laquelle b, z et pd sont tels que définis dans la description.The present invention provides compounds, compositions and methods for the treatment of flavivirideal infections, including hepatitis c virus infections. In some embodiments, the invention provides compounds or compositions of nucleoside derivatives that can be administered either alone or in combination with other antiviral agents. In some embodiments, the compounds are 2'-chloro nucleosides of formula 2001: (2001) or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form or polymorphic form thereof, and wherein b, z and pd are as defined in the description.

MA38084A 2012-10-08 2013-10-07 2'-chloro nucleoside analogues for treating hepatitis c virus infection MA38084A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261711131P 2012-10-08 2012-10-08
PCT/US2013/063731 WO2014058801A1 (en) 2012-10-08 2013-10-07 2'-chloro nucleoside analogs for hcv infection

Publications (1)

Publication Number Publication Date
MA38084A1 true MA38084A1 (en) 2018-03-30

Family

ID=62203551

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38084A MA38084A1 (en) 2012-10-08 2013-10-07 2'-chloro nucleoside analogues for treating hepatitis c virus infection

Country Status (1)

Country Link
MA (1) MA38084A1 (en)

Similar Documents

Publication Publication Date Title
MA41338A (en) PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES
MD20150036A2 (en) 2'-Chloro nucleoside analogs for HCV infection
MA41134B1 (en) Substituted compounds of 5-amino-6h-thiazolo [4,5-d] pyrimidin-2,7-dione for the treatment and prophylaxis of viral infections
MA29240B1 (en) INDOLE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
MA42292B1 (en) Cyclized sulfamoylarylamide derivatives and their use as drugs for the treatment of hepatitis b
MA38323A1 (en) Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
MA37142A3 (en) Derivatives of dihydro-benzo-oxazine and dihydro-pyrido-oxazine
MA46038B1 (en) Sulfonimidoylpurinone compounds substituted in the 7 position for the treatment and prophylaxis of viral infection
MA32711B1 (en) Pyrolidine-2-carboxamide substituted
MA38138A1 (en) New derivatives of quinolone
MA37712A2 (en) Macrocyclic inhibitors of flaviviridae virus
MA34392B1 (en) PYRIMIDINES AS ANTIVIRAL AGENTS
MA35750B1 (en) 2 ', 4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of vhc rna replication (hepatitis c virus)
MA35833B1 (en) Betulin derivatives
MA38675A1 (en) Derivatives of substituted 4'-fluoro-2'-methyl nucleosides useful for inhibiting the replication of hepatitis c (hcv)
MA38315B1 (en) Heterocycle-substituted tetracyclic compounds and methods for their use in the treatment of viral diseases
MY172303A (en) Compositions and methods of use of phorbol esters
MA35443B1 (en) Benzofuran compounds for the treatment of infections with the hepatitis c virus
TN2016000188A1 (en) 2,6-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS
MA31598B1 (en) ANTIVIRAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE
MA35893B1 (en) Heterocyclic amide derivatives as p2x7 receptor antagonists
MA54653B1 (en) Modulators of the cxcr7 piperidine receptor
MA34760B1 (en) COMPOUNDS AND THEIR USE
MA39165A1 (en) Benzimidazole-proline derivatives for their use in the treatment of crepuscular state syndrome
MA38679B1 (en) Cxcr7 receiver modulators